Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arijit Ganguli

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Journal of Comparative Effectiveness Research|November 19, 2013
Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the UK, Germany, France, Spain and Italy (EU-5): results from a physician surveyMitch DeKoven, Vijayveer Bonthapally, Xiaolong Jiao, et al.
Advances in Therapy|April 17, 2016
Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid ArthritisZheng-Yi Zhou, Jenny Griffith, Ella Xiaoyan Du, et al.
Current Medical Research and Opinion|January 9, 2016
An indirect comparison and cost per responder analysis of adalimumab, methotrexate and apremilast in the treatment of methotrexate-naïve patients with psoriatic arthritisKeith A Betts, Jenny Griffith, Alan Friedman, et al.
Dermatology and Therapy|October 12, 2018
The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data AnalysisAlexandra B Kimball, Murali Sundaram, Genevieve Gauthier, et al.
Journal of Drugs in Dermatology : JDD|February 21, 2018
Prevalence of Psoriasis in Children and Adolescents in the United States: A Claims-Based AnalysisAmy S Paller, Rakesh Singh, Martin Cloutier, et al.
Journal of the American Academy of Dermatology|March 3, 2018
The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor-α inhibitors versus phototherapy: An observational cohort studyJashin J Wu, Murali Sundaram, Martin Cloutier, et al.
Rheumatology and Therapy|October 18, 2016
Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing SpondylitisKeith A Betts, Jenny Griffith, Yan Song, et al.
Clinical Therapeutics|July 24, 2017
Systematic Literature Review and Meta-analysis of Tumor Necrosis Factor-Alpha Experienced Rheumatoid ArthritisAlvin F Wells, Jeffrey R Curtis, Keith A Betts, et al.
Rheumatology (Oxford, England)|April 27, 2016
Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexatePaul Emery, Josef S Smolen, Arijit Ganguli, et al.
Journal of Drugs in Dermatology : JDD|February 21, 2018
Increased Prevalence of Cancer in Adult Patients With Psoriasis in the United States: A Claims Based AnalysisAlexandra B Kimball, Murali Sundaram, Martin Cloutier, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Journal of Comparative Effectiveness Research|November 19, 2013
Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the UK, Germany, France, Spain and Italy (EU-5): results from a physician surveyMitch DeKoven, Vijayveer Bonthapally, Xiaolong Jiao, et al.
Advances in Therapy|April 17, 2016
Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid ArthritisZheng-Yi Zhou, Jenny Griffith, Ella Xiaoyan Du, et al.
Current Medical Research and Opinion|January 9, 2016
An indirect comparison and cost per responder analysis of adalimumab, methotrexate and apremilast in the treatment of methotrexate-naïve patients with psoriatic arthritisKeith A Betts, Jenny Griffith, Alan Friedman, et al.
Dermatology and Therapy|October 12, 2018
The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data AnalysisAlexandra B Kimball, Murali Sundaram, Genevieve Gauthier, et al.
Journal of Drugs in Dermatology : JDD|February 21, 2018
Prevalence of Psoriasis in Children and Adolescents in the United States: A Claims-Based AnalysisAmy S Paller, Rakesh Singh, Martin Cloutier, et al.
Journal of the American Academy of Dermatology|March 3, 2018
The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor-α inhibitors versus phototherapy: An observational cohort studyJashin J Wu, Murali Sundaram, Martin Cloutier, et al.
Rheumatology and Therapy|October 18, 2016
Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing SpondylitisKeith A Betts, Jenny Griffith, Yan Song, et al.
Clinical Therapeutics|July 24, 2017
Systematic Literature Review and Meta-analysis of Tumor Necrosis Factor-Alpha Experienced Rheumatoid ArthritisAlvin F Wells, Jeffrey R Curtis, Keith A Betts, et al.
Rheumatology (Oxford, England)|April 27, 2016
Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexatePaul Emery, Josef S Smolen, Arijit Ganguli, et al.
Journal of Drugs in Dermatology : JDD|February 21, 2018
Increased Prevalence of Cancer in Adult Patients With Psoriasis in the United States: A Claims Based AnalysisAlexandra B Kimball, Murali Sundaram, Martin Cloutier, et al.
Pageof 7